Lamiae Grimaldi-Bensouda
Overview
Explore the profile of Lamiae Grimaldi-Bensouda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
509
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Grimaldi-Bensouda L, Abenhaim L
Therapie
. 2018 Nov;
74(2):199-207.
PMID: 30470476
The systematic case-referent method is a special case-referent design originally developed for pharmacoepidemiologic research purposes. It consists in the systematic collection of series of incident cases of various disorders and...
12.
Nordon C, Grimaldi-Bensouda L, Pribil C, Nachbaur G, Amzal B, Thabut G, et al.
Respir Med
. 2018 Oct;
144:42-49.
PMID: 30366583
Objective: To describe the clinical and economic burden of severe asthma in France over 12 months. Methods: Data were retrieved from the observational, prospective "Cohorte Obstruction Bronchique et Asthme" (COBRA)...
13.
Grimaldi-Bensouda L, Wedemeyer H, Wiegand J, Lohse A, Benichou J, Rossignol M, et al.
Int J Cardiol
. 2018 Jun;
266:100-105.
PMID: 29887424
Background: Spontaneous reports of acute liver injuries (ALI) in patients taking dronedarone triggered an EMA alert in 2011. This study aimed to assess the risk of ALI for class III...
14.
Grimaldi-Bensouda L, Danchin N, Dallongeville J, Falissard B, Furber A, Cottin Y, et al.
Heart
. 2018 Mar;
104(19):1583-1592.
PMID: 29535227
Objective: To compare ticagrelor and prasugrel with clopidogrel for recurrent fatal and non-fatal myocardial infarction (reMI) in real-life conditions. Methods: Case-referent study using the Pharmacoepidemiological General Research eXtension (PGRx)-acute coronary...
15.
Jalbert J, Rossignol M, Astruc B, Bayle F, Nordon C, Avouac B, et al.
J Popul Ther Clin Pharmacol
. 2017 Jun;
24(2):e61-e70.
PMID: 28594483
Background: Long-acting injectable (LAI) atypical antipsychotics are associated with improved adherence and reduced relapse rates in schizophrenia but reminder-based interventions may further improve outcomes. Objectives: To assess an institutional medication...
16.
Malandain L, Thibaut F, Grimaldi-Bensouda L, Falissard B, Abenhaim L, Nordon C
Schizophr Res
. 2017 Jun;
192:213-218.
PMID: 28558905
Reasons for using antipsychotic polypharmacy (APP) in routine clinical practice, despite a potentially unfavorable risk-benefit ratio, are poorly understood. This research aimed to determine (1) if severe courses of schizophrenia...
17.
Grimaldi-Bensouda L, Rossignol M, Kone-Paut I, Krivitzky A, Lebrun-Frenay C, Clet J, et al.
J Autoimmun
. 2017 Feb;
79:84-90.
PMID: 28190705
Background: Safety of HPV vaccines is still in question due to reports of autoimmune diseases (ADs) following HPV immunization. Objectives: To assess the risk of ADs associated with HPV vaccination...
18.
Grimaldi-Bensouda L, Nordon C, Rossignol M, Jardon V, Boss V, Warembourg F, et al.
Pharmacoepidemiol Drug Saf
. 2017 Jan;
26(3):239-247.
PMID: 28052554
Purpose: Randomized-controlled trials and claims databases suggest that antiepileptic drug (AED) use may increase the risk of suicide attempts (SA). The present case-control study explores the impact of underlying indications...
19.
Ferrieres J, Dallongeville J, Rossignol M, Benichou J, Caro J, Getsios D, et al.
J Clin Lipidol
. 2016 Dec;
10(6):1379-1388.
PMID: 27919355
Background: To evaluate the real-life impact of ezetimibe on cardiovascular (CV) morbidity and mortality in France. Objective: To estimate the number of non-fatal and fatal CV events that could be...
20.
Grimaldi-Bensouda L, Nordon C, Leblanc T, Abenhaim L, Allali S, Armari-Alla C, et al.
Pediatr Blood Cancer
. 2016 Dec;
64(7).
PMID: 27905681
Objectives: Nationwide prospective cohort study exploring (i) the factors associated with treatment initiation (vs. watchful waiting) in children with primary immune thrombocytopenia (ITP) followed in routine clinical practice and (ii)...